
201 - 500 employees
Founded 2009
🧬 Biotechnology
💊 Pharmaceuticals
💰 $120M Later Stage VC (Series A) on 2021-09
Biotechnology • Pharmaceuticals
AbelZeta is a clinical-stage biopharmaceutical company (presenting itself as AbelZeta Pharma) focused on developing cell-based oncology therapies. Public information shows they recently regained global rights to C-CAR039 (Prizlon-cel), a CAR-T cell therapy candidate, and received FDA clearance of an IND application to study it in large B‑cell lymphoma, indicating an emphasis on hematologic cancer therapeutics and clinical development/licensing activities.
🔥 6 minutes ago
Where this job comes from
Posted on AbelZeta's careers page, not through a job board
First seen by Remote Rocketship 6 minutes ago

201 - 500 employees
Founded 2009
🧬 Biotechnology
💊 Pharmaceuticals
💰 $120M Later Stage VC (Series A) on 2021-09
Biotechnology • Pharmaceuticals
AbelZeta is a clinical-stage biopharmaceutical company (presenting itself as AbelZeta Pharma) focused on developing cell-based oncology therapies. Public information shows they recently regained global rights to C-CAR039 (Prizlon-cel), a CAR-T cell therapy candidate, and received FDA clearance of an IND application to study it in large B‑cell lymphoma, indicating an emphasis on hematologic cancer therapeutics and clinical development/licensing activities.
• Serve as Study Medical Lead for one or more clinical trials • Provide day-to-day clinical oversight from study start-up through database lock and clinical study reporting • Perform or oversee medical monitoring activities, including eligibility review, AEs, SAEs, concomitant medications, rescue therapy review, protocol deviations, and data queries • Review subject-level clinical data in EDC and related data-review platforms • Provide medical guidance to investigators and sites on protocol interpretation, eligibility, disease management, safety events, and study-specific clinical questions • Lead or contribute to protocols, amendments, investigator brochures, informed consent forms, medical monitoring plans, clinical sections of statistical analysis plans, clinical study reports, and other core study documents • Integrate disease biology, clinical phenotype, standard of care, translational findings, PK/PD, biomarker data, and emerging safety/efficacy data into study-level decisions and future development strategy • Identify study risks and propose mitigation strategies to ensure high-quality, timely, inspection-ready trial execution • Participate in and increasingly help lead regulatory interactions related to expedited programs, protocol alignment, pivotal development, and registrational strategy • Build relationships with investigators, key opinion leaders, advisory boards, patient advocacy organizations, and external experts • Develop expertise in clinical and operational considerations unique to autologous CAR-T and other advanced therapies • Partner with Safety and clinical experts on CRS, ICANS/neurotoxicity, infections, cytopenias, and disease-specific complications • Partner with Clinical Operations, Data Management, Pharmacovigilance/Safety, Biostatistics, Translational Medicine, Regulatory Affairs, Medical Writing, CMC/Technical Operations, and CRO partners
• MD, DO, or equivalent medical degree required • Board certification/board eligibility in Rheumatology, Neurology, Neuroimmunology/Multiple Sclerosis, Clinical Immunology, or another specialty with substantial autoimmune-disease expertise • Meaningful clinical experience caring for patients with autoimmune, rheumatologic, or neuroimmunology disease • Demonstrated understanding of clinical-trial methodology, GCP, patient safety, and clinical data interpretation • Strong written and verbal communication skills • Ability to operate effectively in a highly matrixed, fast-moving environment • Industry clinical-development experience as a study physician, medical monitor, or clinical development experience; or academic clinical trial investigator • Hands-on medical monitoring and EDC/data-review experience • Experience designing or executing Phase 1, Phase 1b/2, Phase 2, pivotal, or registrational clinical trials • Experience with CAR-T, cell therapy, gene therapy, hematopoietic stem-cell transplantation, immune effector-cell therapy, or other advanced therapeutic modalities • Experience with biomarkers, translational medicine, precision medicine, pharmacodynamic endpoints, or mechanistically driven patient-selection strategies • Experience supporting regulatory submissions or direct health-authority interactions • Ability to engage investigators and KOLs as a physician peer while maintaining sponsor accountability • Ability to collaborate across Clinical Operations, Safety, Regulatory, Biometrics, Translational Medicine, CMC, Research, and external partners • Ability to prioritize, make decisions with incomplete information, and operate effectively in a growing biotechnology company
• 100% company paid medical, dental, vision, life insurance, short-term and long-term disability insurance • Competitive company 401k match • Paid holidays, sick leave, and annual leave • Defined career path • Annual performance review and feedback process
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🔥 7 hours ago
501 - 1000
Senior Director leading Medical Affairs operations for Satsuma Pharmaceuticals, a biopharmaceutical company launching an approved migraine therapy. Overseeing Medical Information, systems, vendors, publications, grants, and launch readiness.
🇺🇸 United States – Remote
💵 $255k - $295k / year
💰 Debt financing on 2017-06
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🔥 12 hours ago
Medical Information and Medical Review leader supporting Immunic’s vidofludimus calcium and multiple sclerosis pipeline. Building scalable scientific inquiry, review, and launch-readiness capabilities.
🔥 12 hours ago
Clinical Study Lead overseeing global Phase 1-3 trial execution for Immunic Therapeutics. Managing CROs, sites, risks, budgets, and regulatory-compliant study delivery.
🔥 12 hours ago
Medical Science Liaison leader building MSL teams for REGENXBIO’s AAV gene therapy programs. Supporting neuromuscular/DMD clinical development, KOL engagement, advisory boards, and medical congresses.
🇺🇸 United States – Remote
💵 $206k - $340k / year
🔥 Funding within the last year
💰 $100M Post-IPO Equity on 2026-07
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🔥 13 hours ago
Medical Director leading U.S. medical strategy for Amgen’s investigational obesity and cardiovascular therapy. Driving evidence generation, stakeholder engagement, and launch readiness.
🇺🇸 United States – Remote
💵 $217.7k - $294.5k / year
💰 $28.5G Post-IPO Debt on 2022-12
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🦅 H1B Visa Sponsor